img

Global RNAi Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global RNAi Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

RNAi Therapy is a new treatment method that uses RNA interference (RNA interference, RNAi) to treat diseases. RNA interference refers to the introduction of double-stranded RNA molecules, so that the mRNA molecules of a specific gene cannot be translated into proteins, thereby achieving the purpose of inhibiting the expression of the gene. RNAi therapy utilizes the human body's own gene regulation mechanism. It has strong targeting, good therapeutic effect, and few side effects. It is a new type of treatment with great potential.
RNAi Therapy report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global RNAi Therapy market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Oncology and Cardiology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for RNAi Therapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, RNAi Therapy key companies include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence and Sirnaomics, etc. Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals are top 3 players and held % share in total in 2022.
RNAi Therapy can be divided into Small Molecule Interfering Ribonucleic Acid (SiRNA) and Microrna (MiRNA), etc. Small Molecule Interfering Ribonucleic Acid (SiRNA) is the mainstream product in the market, accounting for % share globally in 2022.
RNAi Therapy is widely used in various fields, such as Oncology, Cardiology and Others,, etc. Oncology provides greatest supports to the RNAi Therapy industry development. In 2022, global % share of RNAi Therapy went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global RNAi Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Alnylam
Sarepta Therapeutics
Alnylam Pharmaceuticals
Moderna
Sanofi
Arcturus Therapeutics
Silence
Sirnaomics
Segment by Type
Small Molecule Interfering Ribonucleic Acid (SiRNA)
Microrna (MiRNA)

Segment by Application


Oncology
Cardiology
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the RNAi Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, RNAi Therapy introduction, etc. RNAi Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of RNAi Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of RNAi Therapy
1.1 RNAi Therapy Market Overview
1.1.1 RNAi Therapy Product Scope
1.1.2 RNAi Therapy Market Status and Outlook
1.2 Global RNAi Therapy Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global RNAi Therapy Market Size by Region (2018-2033)
1.4 Global RNAi Therapy Historic Market Size by Region (2018-2023)
1.5 Global RNAi Therapy Market Size Forecast by Region (2024-2033)
1.6 Key Regions, RNAi Therapy Market Size (2018-2033)
1.6.1 North America RNAi Therapy Market Size (2018-2033)
1.6.2 Europe RNAi Therapy Market Size (2018-2033)
1.6.3 Asia-Pacific RNAi Therapy Market Size (2018-2033)
1.6.4 Latin America RNAi Therapy Market Size (2018-2033)
1.6.5 Middle East & Africa RNAi Therapy Market Size (2018-2033)
2 RNAi Therapy Market by Type
2.1 Introduction
2.1.1 Small Molecule Interfering Ribonucleic Acid (SiRNA)
2.1.2 Microrna (MiRNA)
2.2 Global RNAi Therapy Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global RNAi Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global RNAi Therapy Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America RNAi Therapy Revenue Breakdown by Type (2018-2033)
2.3.2 Europe RNAi Therapy Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific RNAi Therapy Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America RNAi Therapy Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa RNAi Therapy Revenue Breakdown by Type (2018-2033)
3 RNAi Therapy Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardiology
3.1.3 Others
3.2 Global RNAi Therapy Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global RNAi Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global RNAi Therapy Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America RNAi Therapy Revenue Breakdown by Application (2018-2033)
3.3.2 Europe RNAi Therapy Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific RNAi Therapy Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America RNAi Therapy Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa RNAi Therapy Revenue Breakdown by Application (2018-2033)
4 RNAi Therapy Competition Analysis by Players
4.1 Global RNAi Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNAi Therapy as of 2022)
4.3 Date of Key Players Enter into RNAi Therapy Market
4.4 Global Top Players RNAi Therapy Headquarters and Area Served
4.5 Key Players RNAi Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 RNAi Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alnylam
5.1.1 Alnylam Profile
5.1.2 Alnylam Main Business
5.1.3 Alnylam RNAi Therapy Products, Services and Solutions
5.1.4 Alnylam RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Alnylam Recent Developments
5.2 Sarepta Therapeutics
5.2.1 Sarepta Therapeutics Profile
5.2.2 Sarepta Therapeutics Main Business
5.2.3 Sarepta Therapeutics RNAi Therapy Products, Services and Solutions
5.2.4 Sarepta Therapeutics RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Sarepta Therapeutics Recent Developments
5.3 Alnylam Pharmaceuticals
5.3.1 Alnylam Pharmaceuticals Profile
5.3.2 Alnylam Pharmaceuticals Main Business
5.3.3 Alnylam Pharmaceuticals RNAi Therapy Products, Services and Solutions
5.3.4 Alnylam Pharmaceuticals RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Moderna Recent Developments
5.4 Moderna
5.4.1 Moderna Profile
5.4.2 Moderna Main Business
5.4.3 Moderna RNAi Therapy Products, Services and Solutions
5.4.4 Moderna RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Moderna Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi RNAi Therapy Products, Services and Solutions
5.5.4 Sanofi RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Arcturus Therapeutics
5.6.1 Arcturus Therapeutics Profile
5.6.2 Arcturus Therapeutics Main Business
5.6.3 Arcturus Therapeutics RNAi Therapy Products, Services and Solutions
5.6.4 Arcturus Therapeutics RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Arcturus Therapeutics Recent Developments
5.7 Silence
5.7.1 Silence Profile
5.7.2 Silence Main Business
5.7.3 Silence RNAi Therapy Products, Services and Solutions
5.7.4 Silence RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Silence Recent Developments
5.8 Sirnaomics
5.8.1 Sirnaomics Profile
5.8.2 Sirnaomics Main Business
5.8.3 Sirnaomics RNAi Therapy Products, Services and Solutions
5.8.4 Sirnaomics RNAi Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Sirnaomics Recent Developments
6 North America
6.1 North America RNAi Therapy Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe RNAi Therapy Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific RNAi Therapy Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America RNAi Therapy Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa RNAi Therapy Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 RNAi Therapy Market Dynamics
11.1 RNAi Therapy Industry Trends
11.2 RNAi Therapy Market Drivers
11.3 RNAi Therapy Market Challenges
11.4 RNAi Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market RNAi Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global RNAi Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global RNAi Therapy Market Size Share by Region (2018-2023)
Table 4. Global RNAi Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global RNAi Therapy Forecasted Market Size Share by Region (2024-2033)
Table 6. Global RNAi Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global RNAi Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global RNAi Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global RNAi Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global RNAi Therapy Revenue Market Share by Type (2024-2033)
Table 11. North America RNAi Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America RNAi Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe RNAi Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe RNAi Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific RNAi Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific RNAi Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America RNAi Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America RNAi Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa RNAi Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa RNAi Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global RNAi Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global RNAi Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global RNAi Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global RNAi Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global RNAi Therapy Revenue Market Share by Application (2024-2033)
Table 26. North America RNAi Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America RNAi Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe RNAi Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe RNAi Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific RNAi Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific RNAi Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America RNAi Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America RNAi Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa RNAi Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa RNAi Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global RNAi Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global RNAi Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNAi Therapy as of 2022)
Table 39. Date of Key Players Enter into RNAi Therapy Market
Table 40. Global RNAi Therapy Key Players Headquarters and Area Served
Table 41. RNAi Therapy Product Solution and Service
Table 42. Global RNAi Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Alnylam Basic Information List
Table 45. Alnylam Description and Business Overview
Table 46. Alnylam RNAi Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in RNAi Therapy Business of Alnylam (2018-2023)
Table 48. Alnylam Recent Developments
Table 49. Sarepta Therapeutics Basic Information List
Table 50. Sarepta Therapeutics Description and Business Overview
Table 51. Sarepta Therapeutics RNAi Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in RNAi Therapy Business of Sarepta Therapeutics (2018-2023)
Table 53. Sarepta Therapeutics Recent Developments
Table 54. Alnylam Pharmaceuticals Basic Information List
Table 55. Alnylam Pharmaceuticals Description and Business Overview
Table 56. Alnylam Pharmaceuticals RNAi Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in RNAi Therapy Business of Alnylam Pharmaceuticals (2018-2023)
Table 58. Alnylam Pharmaceuticals Recent Developments
Table 59. Moderna Basic Information List
Table 60. Moderna Description and Business Overview
Table 61. Moderna RNAi Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in RNAi Therapy Business of Moderna (2018-2023)
Table 63. Moderna Recent Developments
Table 64. Sanofi Basic Information List
Table 65. Sanofi Description and Business Overview
Table 66. Sanofi RNAi Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in RNAi Therapy Business of Sanofi (2018-2023)
Table 68. Sanofi Recent Developments
Table 69. Arcturus Therapeutics Basic Information List
Table 70. Arcturus Therapeutics Description and Business Overview
Table 71. Arcturus Therapeutics RNAi Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in RNAi Therapy Business of Arcturus Therapeutics (2018-2023)
Table 73. Arcturus Therapeutics Recent Developments
Table 74. Silence Basic Information List
Table 75. Silence Description and Business Overview
Table 76. Silence RNAi Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in RNAi Therapy Business of Silence (2018-2023)
Table 78. Silence Recent Developments
Table 79. Sirnaomics Basic Information List
Table 80. Sirnaomics Description and Business Overview
Table 81. Sirnaomics RNAi Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in RNAi Therapy Business of Sirnaomics (2018-2023)
Table 83. Sirnaomics Recent Developments
Table 84. North America RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 86. Europe RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 88. Asia-Pacific RNAi Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 89. Asia-Pacific RNAi Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific RNAi Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific RNAi Therapy Market Share by Region (2018-2023)
Table 92. Asia-Pacific RNAi Therapy Market Share by Region (2024-2033)
Table 93. Latin America RNAi Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 94. Latin America RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 96. Middle East & Africa RNAi Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 97. Middle East & Africa RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 99. RNAi Therapy Market Trends
Table 100. RNAi Therapy Market Drivers
Table 101. RNAi Therapy Market Challenges
Table 102. RNAi Therapy Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi Therapy Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global RNAi Therapy Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global RNAi Therapy Market Share by Regions: 2022 VS 2033
Figure 4. Global RNAi Therapy Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America RNAi Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe RNAi Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific RNAi Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America RNAi Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa RNAi Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Small Molecule Interfering Ribonucleic Acid (SiRNA)
Figure 11. Global Small Molecule Interfering Ribonucleic Acid (SiRNA) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Microrna (MiRNA)
Figure 13. Global Microrna (MiRNA) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global RNAi Therapy Market Size Share by Type: 2022 & 2033
Figure 15. North America RNAi Therapy Revenue Market Share by Type (2018-2033)
Figure 16. Europe RNAi Therapy Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific RNAi Therapy Revenue Market Share by Type (2018-2033)
Figure 18. Latin America RNAi Therapy Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa RNAi Therapy Revenue Market Share by Type (2018-2033)
Figure 20. Oncology Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Cardiology Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global RNAi Therapy Market Size Share by Application: 2022 & 2033
Figure 24. North America RNAi Therapy Revenue Market Share by Application (2018-2033)
Figure 25. Europe RNAi Therapy Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific RNAi Therapy Revenue Market Share by Application (2018-2033)
Figure 27. Latin America RNAi Therapy Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa RNAi Therapy Revenue Market Share by Application (2018-2033)
Figure 29. RNAi Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players RNAi Therapy Market Share in 2022
Figure 31. North America RNAi Therapy Market Share by Country (2018-2033)
Figure 32. United States RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 33. Canada RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 34. Germany RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 35. France RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 37. Italy RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 38. Russia RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific RNAi Therapy Market Share by Region (2018-2033)
Figure 41. China RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 42. Japan RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 45. India RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 46. Australia RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America RNAi Therapy Market Share by Country (2018-2033)
Figure 48. Mexico RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa RNAi Therapy Market Share by Country (2018-2033)
Figure 51. Turkey RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 53. UAE RNAi Therapy Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries